YOUR PRODUCT

Tailored Development and Analytical Services for your Product

Quality services tailored to your drug product

Your molecule and product type is unique and deserves special attention from an expert partner. Coriolis scientific expertise, with a large variety of diverse molecules, therapies and drug products, combined with our many years of experience with challenging pharmaceutical development projects, makes us your ideal expert partner.

Coriolis provides flexible and science-driven solutions tailored to the needs of your product and development phase.
Whether your product is an antibody, a viral vector, or an mRNA vaccine, whether you need a liquid or lyophilized drug product, we devise scientifically sound strategies which will de-risk your development.

In a collaborative partnership, we align our services with your development strategy and focus on achieving your target product profile (TPP). Together, we will make future therapies available to patients and will improve the quality of life for humankind.

High quality services specific to your drug product

We provide development and analytical services for a large variety of active pharmaceutical ingredients and drug products. Select your product type and explore our product specific solutions.

Select your product type

Antibody or related product

Let's talk!

Get in touch with our experts today to discuss your questions and inquiries.

Get in contact

Flexible solutions suitable for your development stage

Active pharmaceutical ingredient (API) and/or drug substance availability, timeline requirements, and the need for method qualification or validation differs significantly between discovery, preclinical and clinical stage.

Accordingly, all projects at Coriolis are tailored to the development stage of your drug product. We focus on your specific needs and target product profile when compiling a study plan, so you achieve your development goals without changing your overall strategy or exhausting your precious drug substance material or timelines.

Reach your development goals faster

Highly experienced scientists, a large portfolio of in-house analytical methods and an expert panel of scientific advisors are the best prerequisites for a streamlined and fast road to success. The project team at Coriolis will be working in close collaboration with you and not only you will receive a detailed and scientifically reviewed development report at the end of the project, but we will share and discuss new data with you as soon as available to enable a fast decision making and a rapid advancement of your development program.

Liquid and lyophilized drug product development in one hand

For most biopharmaceuticals, a liquid formulation is desired. However, if the anticipated stability or shelf-life cannot be achieved, or you aim to enter the clinics fast at low risk, lyophilization is a valuable alternative. Coriolis combines many years of experience in developing liquid and lyophilized formulations, subsequently or in parallel, with a large portfolio of analytical techniques for both, liquid and lyophilized samples. We tailor the formulation development approach to fit your timelines and budget. This includes the design, development, optimization, robustness testing, scale-up, and transfer of entire freeze-drying processes or liquid formulation procedures.

Development projects for biosafety level S1 and S2 material

Innovative therapies including gene- and cell therapy frequently utilize genetically modified organisms that fall under biosafety level S1 or S2. We take care of the biological safety assessment and regulatory paperwork to get project work started in a timely manner. In our dedicated ATMP development facilities, we develop and analyze liquid and lyophilized drug products up to biosafety level S2 (e.g., viral vectors or cell therapy products).

Contact us

Please contact our business development team with your questions and inquiries.

Click here to contact our experts today